Webinar Japan Mission 2024
08.05.2024 - 9:30
08.05.2024 - 11:00
Online
Biocat
Generalitat de Catalunya, ACCIÓ, ATR, Japan Bioindustry Association, Kobe Biomedical Innovation Cluster i Osaka Bio Headquarters
Are you interested in participating in BioJapan 2024 and learning more about the Japanese healthcare ecosystem? On 8 May, from 9:30 to 11am (CEST), Biocat is organising an informative webinar to learn more about local partners, Japan's innovative ecosystem, the features of BioJapan2024 and everything you can explore.
Program
- Mònica Castellà, Delegate of the Government of Catalonia in Japan.
- Yuko Kijimoto, ACCIÓ Representative, Director of the Foreign Trade and Investment Office of Catalonia in Tokyo.
- Núria Martí, Director of Innovation and Business Development at Biocat.
KANSAI AREA
- Minato Suzuki, Osaka BioHeadQuarters & Osaka Prefectural Government
- Keiko Kobayashi, KBIC (Kobe Biomedical Innovation Cluster)
- Hiroyuki Suzuki, ATR (Advanced Telecommunications Research Institute)
KANTO AREA
- Dr. Toru Yamada, Ph.D., Japan Bioindustry Association(JBA)/GTB/BioJapan
- Ana Pilar Gonzalez, Chief Operating Officer (COO) de AGC Pharma Chemicals
- Nere García, Plant Director / Site Director at Reig Jofré
- Núria Martí and Clara Mediñà, Biocat
BioJapan 2024
Japan is defined as one of the world's most stable and powerful economies, and this translates into innovation, market and business opportunities in the world of science and technology, as well as being a pioneer in regenerative medicine, healthcare technology and digitalisation.
For this reason, Biocat is organising an itinerary from 7 to 11 October to visit the Kansai (Osaka) and Kanto (Yokohama) areas.
- On 7-8 October, events will be held in the Osaka area in cooperation with the EU Japan Centre and the Osaka Government, offering partnership opportunities, networking and exclusive visits to their ecosystem.
- From 9 to 11 October, BioJapan 2024 will be held in Yokohama, close to Tokyo and one of the most powerful innovation areas and hubs in the life sciences, and will be one of the largest congresses in Asia in the field of bio and regenerative medicine.